Hypocomplementemic Urticarial Vasculitis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Hypocomplementemic Urticarial Vasculitis

What is the definition of Hypocomplementemic Urticarial Vasculitis?
Hypocomplementemic urticarial vasculitis (HUV) is a rare form of vasculitis characterized by inflammation of the small blood vessels and low levels of complement proteins in the blood. HUV causes recurrent episodes of hives (urticaria) and painful skin lesions that itch or burn. Individuals with HUV may also have systemic, multiorgan involvement, causing arthritic joint pain; pulmonary (lung) disease; ocular (eye) inflammation; kidney inflammation; or various other symptoms. Some scientists refer to the condition as HUV syndrome (HUVS) when it is more severe and there is significant systemic involvement. Other scientists call the condition HUVS in the absence of systemic disease. In some cases, the terms are used as synonyms. There appears to be controversy regarding the nomenclature and classification of HUV and HUVS, and whether they are distinct conditions or represent a continuum of the same disease. Both genetic and environmental factors are thought to play a role in causing HUV. It generally occurs sporadically, but familial cases have been reported. It is thought to develop due to an abnormal immune system response involving specific proteins that work together to fight organisms that cause infections. In some cases HUV may be associated with an underlying infection or systemic diseases such as systemic lupus, Sjögren's syndrome, monoclonal gammopathy, or blood disorders.
What are the alternative names for Hypocomplementemic Urticarial Vasculitis?
  • Hypocomplementemic urticarial vasculitis
  • Anti-C1q vasculitis
  • Mac Duffie hypocomplementemic urticarial vasculitis
  • Mac Duffie syndrome
  • McDuffie hypocomplementemic urticarial vasculitis
  • McDuffie syndrome
Who are the top Hypocomplementemic Urticarial Vasculitis Local Doctors?
Advanced in Hypocomplementemic Urticarial Vasculitis
Advanced in Hypocomplementemic Urticarial Vasculitis
Referral may be required

Rheumatology At Village Pointe Health Center

110 N 175th St., Level 2, 
Omaha, NE 
Experience:
22+ years
Languages Spoken:
English
Offers Telehealth

Michael Feely is a Rheumatologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 22 years. Dr. Feely is rated as an Advanced provider by MediFind in the treatment of Hypocomplementemic Urticarial Vasculitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Rheumatoid Arthritis (RA), and Necrotizing Vasculitis.

Elite in Hypocomplementemic Urticarial Vasculitis
Elite in Hypocomplementemic Urticarial Vasculitis
Referral may be required
12, Rue De L'Ecole De Médecine, 
Paris, FR 

Marie Jachiet practices practicing medicine in Paris, France. Ms. Jachiet is rated as an Elite expert by MediFind in the treatment of Hypocomplementemic Urticarial Vasculitis. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Hypocomplementemic Urticarial Vasculitis, Polyarteritis Nodosa, Atopic Dermatitis, and Vasculitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hypocomplementemic Urticarial Vasculitis
Elite in Hypocomplementemic Urticarial Vasculitis
Referral may be required
Fatih, TR 

Ahmet Gul practices practicing medicine in Fatih, Turkey. Mr. Gul is rated as an Elite expert by MediFind in the treatment of Hypocomplementemic Urticarial Vasculitis. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Familial Mediterranean Fever, Behcet Disease, Vasculitis, Tissue Biopsy, and Kidney Transplant.

What are the latest Hypocomplementemic Urticarial Vasculitis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center